Alkami Technology Inc header image

Alkami Technology Inc

ALKT

Equity

ISIN null / Valor 110527431

NASDAQ (2025-12-23)
USD 23.08-0.94%

Alkami Technology Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Alkami Technology Inc. provides cloud-based digital banking solutions to financial institutions, enabling them to offer enhanced online and mobile banking experiences to their customers.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (22.11.2025):

Alkami Technology, Inc. reported results for the second quarter of 2025 (Q2 2025). GAAP total revenue rose to $112.1 million (up 36.4% year‑over‑year). The company posted a GAAP net loss of $(13.6) million while delivering Adjusted EBITDA of $11.9 million. Alkami exited the quarter with 20.9 million users and $424 million in annual recurring revenue (ARR), and provided guidance for Q3 2025 and full‑year 2025 revenue and Adjusted EBITDA ranges.

Revenue and Growth

GAAP total revenue was $112.1 million in Q2 2025, a 36.4% increase versus Q2 2024, driven by continued demand for digital banking conversions and product adoption.

Margins

GAAP gross margin was 58.6% (vs. 59.4% year‑ago). Non‑GAAP gross margin improved to 65.1% from 63.2% in the year‑ago quarter, reflecting adjustments that exclude amortization and stock‑based compensation.

Profitability Metrics

GAAP net loss widened slightly to $(13.6) million in Q2 2025 (vs. $(12.3) million a year earlier). Adjusted EBITDA rose substantially to $11.9 million (vs. $4.6 million in Q2 2024), indicating stronger underlying operating performance on a non‑GAAP basis.

Users, ARR and ARPU

Alkami ended Q2 2025 with 20.9 million registered users (up 2.3 million YoY). ARR was $424 million (up 32% YoY) and revenue per registered user increased to $20.28 (up 17% YoY).

MANTL Acquisition Impact

The company cited its recent acquisition of MANTL as strategic for onboarding/account opening; MANTL added 23 clients in Q2 2025, including three tied to new Alkami wins and six that were existing Alkami clients.

Guidance

Q3 2025 guidance: GAAP revenue $112.5M–$114.0M and Adjusted EBITDA $13.0M–$14.0M. Full‑year 2025 guidance: GAAP revenue $443.0M–$447.0M and Adjusted EBITDA $51.5M–$54.0M.

Management Commentary

Management highlighted robust demand among regional and community financial institutions, progress in scaling the business (outperforming Adjusted EBITDA targets by over 25%), and confidence in Alkami’s digital sales, service and onboarding capabilities.

Summarized from source with an LLMView Source

Key figures

-40.7%1Y
69.5%3Y
%5Y

Performance

48.7%1Y
42.9%3Y
48.8%5Y

Volatility

Market cap

2423 M

Market cap (USD)

Daily traded volume (Shares)

863,225

Daily traded volume (Shares)

1 day high/low

38.09 / 36.21

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Integral Ad Science Holding Corp
Integral Ad Science Holding Corp Integral Ad Science Holding Corp Valor: 112024427
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 10.34
Geron Corporation (Delaware)
Geron Corporation (Delaware) Geron Corporation (Delaware) Valor: 145973
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.48%USD 1.33
Neurocrine Biosciences Inc
Neurocrine Biosciences Inc Neurocrine Biosciences Inc Valor: 149044
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.17%USD 147.28
HMS Networks AB
HMS Networks AB HMS Networks AB Valor: 36954778
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.15%SEK 413.00
Jamf Holding Corp
Jamf Holding Corp Jamf Holding Corp Valor: 55782274
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%USD 13.00
FormFactor Inc
FormFactor Inc FormFactor Inc Valor: 1445839
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.40%USD 58.16
Enghouse Systems Ltd
Enghouse Systems Ltd Enghouse Systems Ltd Valor: 384162
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.21%CAD 20.40
TD SYNNEX Corporation
TD SYNNEX Corporation TD SYNNEX Corporation Valor: 1676033
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%USD 153.02
Exelixis Inc
Exelixis Inc Exelixis Inc Valor: 1069927
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.91%USD 46.61
Kura Oncology Inc
Kura Oncology Inc Kura Oncology Inc Valor: 28160920
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-4.26%USD 10.79